Mads Dall
Chairman of the Board
Mads joined Eyenuk’s Board of Directors in December 2024 as Chairman.He brings 30+ years of life sciences business experience and has operated in US, Europe and Asia with Pharma, Biotech and MedTech companies in executive, advisory and board positions. Mads was Vice President at Novo Nordisk until 2005. His most recent executive position was Chief Commercial Officer at Beta Bionics. Mads currently serves as independent director on the board of Adocia, a public French Biotech company, and has previoiusly been a director of several private companies in the US and Europe, including Beta Bionics, and Eyenuk, where he was an independent director until 2019.